Flavonoids in cancer prevention

Anti-Cancer Agents in Medicinal Chemistry

Volumn 12, Issue 8, 2012, Pages 836-851

  Park, Eun Jung ^a   Pezzuto, John M ^a  

^a UNIVERSITY OF HAWAII AT HILO   (United States)

Author keywords

Bioavailability; Cancer prevention; Flavonoids; Methoxylated flavonoids

Indexed keywords

AMENTOFLAVONE; ANTHOCYANIN; APIGENIN; BAICALEIN; CATECHIN; CHRYSIN; DAIDZEIN; EPICATECHIN; EPIGALLOCATECHIN GALLATE; FLAVONOID; FORMONONETIN; GENISTEIN; GENISTIN; GLYCITEIN; HESPERETIN; HISPIDULIN; ICARIIN; ISOQUERCITRIN; KAEMPFEROL; LUTEOLIN; MALVIDIN CHLORIDE; MITOFLAXONE; NOBILETIN; PROANTHOCYANIDIN; QUERCETIN; RUTOSIDE; TANGERETIN; THEAFLAVIN; UNINDEXED DRUG; WOGONIN;

ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CANCER CELL; CANCER PREVENTION; CARCINOGENESIS; CHEMOPROPHYLAXIS; DIET SUPPLEMENTATION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG METABOLISM; DRUG SYNTHESIS; HUMAN; IN VITRO STUDY; INFLAMMATION; MEMBRANE TRANSPORT; NATURAL KILLER CELL; NEOPLASM; NONHUMAN;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; BIOLOGICAL AVAILABILITY; BIOLOGICAL PRODUCTS; FLAVONOIDS; HUMANS; MOLECULAR STRUCTURE; NEOPLASMS;

EID: 84866362742     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/187152012802650075     Document Type: Article

References (209)

1. Ververidis, F.; Trantas, E.; Douglas, C.; Vollmer, G.; Kretzschmar, G.; Panopoulos, N. Biotechnology of flavonoids and other phenylpropanoid-derived natural products. Part I: Chemical diversity, impacts on plant biology and human health. Biotechnol. J., 2007, 2(10), 1214-1234.
2. Winkel-Shirley, B. Flavonoid biosynthesis. A colorful model for genetics, biochemistry, cell biology, and biotechnology. Plant Physiol., 2001, 126(2), 485-493.
3. Passamonti, S.; Terdoslavich, M.; Franca, R.; Vanzo, A.; Tramer, F.; Braidot, E.; Petrussa, E.; Vianello, A. Bioavailability of flavonoids: a review of their membrane transport and the function of bilitranslocase in animal and plant organisms. Curr. Drug Metab., 2009, 10(4), 369-394.
4. Huang, W.Y.; Cai, Y.Z.; Zhang, Y. Natural phenolic compounds from medicinal herbs and dietary plants: potential use for cancer prevention. Nutr. Cancer., 2010, 62(1), 1-20.
5. Scalbert, A.; Williamson, G. Dietary intake and bioavailability of polyphenols. J. Nutr., 2000, 130(8S Suppl), 2073S-2085S.
6. Lotito, S.B.; Frei, B. Consumption of flavonoid-rich foods and increased plasma antioxidant capacity in humans: cause, consequence, or epiphenomenon? Free Radic. Biol. Med., 2006, 41(12), 1727-1746.
7. Velíšek, J.; Davídek, J.; Cejpek, K. Biosynthesis of Food Constituents: Natural Pigments. Part 2 - a Review. Czech. J. Food Sci., 2008, 26(2), 73-98.
8. Pérez-Jiménez, J.; Neveu, V.; Vos, F.; Scalbert, A. Systematic analysis of the content of 502 polyphenols in 452 foods and beverages: an application of the phenol-explorer database. J. Agric. Food Chem., 2010, 58(8), 4959-4969.
9. Cazarolli, L.H.; Zanatta, L.; Alberton, E.H.; Figueiredo, M.S.; Folador, P.; Damazio, R.G.; Pizzolatti, M.G.; Silva, F.R. Flavonoids: prospective drug candidates. Mini Rev. Med. Chem., 2008, 8(13), 1429-1440.
10. Zhao, J.; Dixon, R.A. The 'ins' and 'outs' of flavonoid transport. Trends Plant Sci. 2010, 15(2), 72-80.
11. Iwashina, T. Flavonoid function and activity to plants and other organisms. Biol. Sci. Space, 2003, 17(1), 24-44.
12. Kaefer, C.M.; Milner, J.A. The role of herbs and spices in cancer prevention. J. Nutr. Biochem., 2008, 19(6), 347-361.
13. Bhagwat, S.: Haytowitz, D.B.; Holden, J.M. Nutrient Data Laboratory. USDA Database for the Flavonoid Content of Selected Foods Release 3. 2011, (http://www.ars.usda.gov/SP2UserFiles/Place/12354500/Data/Flav/Flav_R03.pdf).
14. Manthey, J.A.; Grohmann, K. In Flavonoids in the Living System; Manthey, J.A.; Buslig, B.S., Eds.; Plenum Press: New York, 1998, p. 85.
15. Kwan, K.C. Oral bioavailability and first-pass effects. Drug Metab. Dispos., 1997, 25(12), 1329-1336.
16. Chiou, W.L. The rate and extent of oral bioavailability versus the rate and extent of oral absorption: clarification and recommendation of terminology. J. Pharmacokinet. Pharmacodyn., 2001, 28(1), 3-6.
17. Manach, C.; Scalbert, A.; Morand, C.; Rémésy, C.; Jiménez, L. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr., 2004, 79(5), 727-747.
18. Drozdowski, L. A.; Thomson, A.B. Intestinal sugar transport. World J. Gastroenterol., 2006, 12(11), 1657-1670.
19. Aherne, S.A.; O'Brien, N.M. Dietary flavonols: chemistry, food content, and metabolism. Nutrition, 2002, 18(1), 75-81.
20. Bokkenheuser, V.D.; Shackleton, C.H.; Winter, J. Hydrolysis of dietary flavonoids glycosides by strains of intestinal Bacteroides from humans. Biochem. J., 1987, 248(3), 953-956.
21. Walle, T. Absorption and metabolism of flavonoids. Free Radic. Biol. Med., 2004, 36(7), 829-837.
22. Gee, J.M.; Dupont, M.S.; Rhodes, M.J.C.; Johnson, I.T. Quercetin glucosides interact with the intestinal glucose transport pathway. Free Radic. Biol. Med., 1998, 25(1), 19-25.
23. Lampe, J.W. Interindividual differences in response to plant-based diets: implications for cancer risk. Am. J. Clin. Nutr., 2009, 89(5), 1553S-1557S.
24. Gao, S.; Hu, M. Bioavailability challenges associated with development of anti-cancer phenolics. Mini Rev. Med. Chem., 2010, 10(6), 550-567.
25. Kemperman, R.A.; Bolca, S.; Roger, L.C.; Vaughan, E.E. Novel approaches for analyzing gut microbes and dietary polyphenols: challenges and opportunities. Microbiology, 2010, 156(Pt 11), 3224-3231.
26. Jemal, A.; Siegel, R.; Xu, J.; Ward, E. Cancer statistics, 2010. CA Cancer J. Clin., 2010, 60(5), 277-300.
27. Sporn, M.B.; Dunlop, N.M.; Newton, D.L.; Smith, J.M. Prevention of chemical carcinogenesis by vitamin A and its synthetic analogs (retinoids). Fed. Proc., 1976, 35(6), 1332-1338.
28. Morse, M.A.; Stoner, G.D. Cancer chemoprevention: principles and prospects. Carcinogenesis, 1993, 14(9), 1737-1746.
29. Walle, T. Methylation of dietary flavones increases their metabolic stability and chemopreventive effects. Int. J. Mol. Sci., 2009, 10(11), 5002-5019.
30. García-Lafuente, A.; Guillamón, E.; Villares, A.; Rostagno, M.A.; Martínez, J.A. Flavonoids as anti-inflammatory agents: implications in cancer and cardiovascular disease. Inflamm. Res., 2009, 58(9), 537-552.
31. Gandini, S.; Merzenich, H.; Robertson, C.; Boyle, P. Meta-analysis of studies on breast cancer risk and diet: the role of fruit and vegetable consumption and the intake of associated micronutrients. Eur. J. Cancer, 2000, 36(5), 636-646.
32. Kolonel, L.N.; Hankin, J.H.; Whittemore, A.S.; Wu, A.H.; Gallagher, R.P.; Wilkens, L.R.; John, E.M.; Howe, G.R.; Dreon, D.M.; West, D.W.; Paffenbarger, R.S. Jr. Vegetables, fruits, legumes and prostate cancer: a multiethnic case-control study. Cancer Epidemiol. Biomarkers Prev., 2000, 9(8), 795-804.
33. Feskanich, D.; Ziegler, R.G.; Michaud, D.S.; Giovannucci, E.L.; Speizer, F.E.; Willett, W.C.; Colditz, G.A. Prospective study of fruit and vegetable consumption and risk of lung cancer among men and women. J. Natl. Cancer Inst., 2000, 92(22), 1812-1823.
34. Pezzuto, J.M.; Park, E.J.; Park E.J. Autoxidation and antioxidants. Encyclopedia of Pharmaceutical Technology, Fourth Edition, in press.
35. Heim, K.E.; Tagliaferro, A.R.; Bobilya, D.J. Flavonoid antioxidants: chemistry, metabolism and structure-activity relationships. J. Nutr. Biochem., 2002, 13(10), 572-584.
36. Schumacker, P.T. Reactive oxygen species in cancer cells: live by the sword, die by the sword. Cancer Cell. 2006, 10(3), 175-176.
37. Trachootham, D.; Alexandre, J.; Huang, P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach? Nat. Rev. Drug Discov., 2009, 8(7), 579-591.
38. Procházková, D.; Boušová, I.; Wilhelmová, N. Antioxidant and prooxidant properties of flavonoids. Fitoterapia, 2011, 82(4), 513-523.
39. Shih, P.H.; Yeh, C.T.; Yen, G.C. Anthocyanins induce the activation of phase II enzymes through the antioxidant response element pathway against oxidative stress-induced apoptosis. J. Agric. Food Chem., 2007, 55(23), 9427-9435.
40. Choi, E.H.; Chang, H.J.; Cho, J.Y.; Chun, H.S. Cytoprotective effect of anthocyanins against doxorubicin-induced toxicity in H9c2 cardiomyocytes in relation to their antioxidant activities. Food Chem Toxicol., 2007, 45(10), 1873-1881.
41. Shukla, S.; Gupta, S. Apigenin-induced prostate cancer cell death is initiated by reactive oxygen species and p53 activation. Free Radic. Biol. Med., 2008, 44(10), 1833-1845.
42. Miyoshi, N.; Naniwa, K.; Yamada, T.; Osawa, T.; Nakamura, Y. Dietary flavonoids apigenin is a potential inducer of intracellular oxidative stress: the role in the interruptive apoptotic signal. Arch. Biochem. Biophys., 2007, 466(2), 274-282.
43. Choi, S.I.; Jeong, C.S.; Cho, S.Y.; Lee, Y.S. Mechanism of apoptosis induced by apigenin in HepG2 human hepatoma cells: involvement of reactive oxygen species generated by NADPH oxidase. Arch. Pharm. Res., 2007, 30(10), 1328-1335.
44. Hwang, Y.P.; Oh, K.N.; Yun, H.J.; Jeong, H.G. The flavonoids apigenin and luteolin suppress ultraviolet A-induced matrix metalloproteinase-1 expression via MAPKs and AP-1-dependent signaling in HaCaT cells. J. Dermatol. Sci., 2011, 61(1), 23-31.
45. Chou, D.S.; Hsiao, G.; Lai, Y.A.; Tsai, Y.J.; Sheu, J.R. Baicalein induces proliferation inhibition in B16F10 melanoma cells by generating reactive oxygen species via 12-lipoxygenase. Free Radic. Biol. Med., 2009, 46(8), 1197-1203.
46. Chen, Y.C.; Chow, J.M.; Lin, C.W.; Wu, C.Y.; Shen, S.C. Baicalein inhibition of oxidative-stress-induced apoptosis via modulation of ERKs activation and induction of HO-1 gene expression in rat glioma cells C6. Toxicol. Appl. Pharmacol., 2006, 216(2), 263-273.
47. Lee, H.J.; Noh, Y.H.; Lee, D.Y.; Kim, Y.S.; Kim, K.Y.; Chung, Y.H.; Lee, W.B.; Kim, S.S. Baicalein attenuates 6-hydroxydopamineinduced neurotoxicity in SH-SY5Y cells. Eur. J. Cell Biol., 2005, 84(11), 897-905.
48. Yin, F.; Liu, J.; Ji, X.; Wang, Y.; Zidichouski, J.; Zhang, J. Baicalin prevents the production of hydrogen peroxide and oxidative stress induced by Aβ aggregation in SH-SY5Y cells. Neurosci. Lett., 2011, 492(2), 76-79.
49. Nakazato, T.; Ito, K.; Ikeda, Y.; Kizaki, M. Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species. Clin. Cancer Res., 2005, 11(16), 6040-6049.
50. Jin, S.; Zhang, Q.Y.; Kang, X.M.; Wang, J.X.; Zhao, W.H. Daidzein induces MCF-7 breast cancer cell apoptosis via the mitochondrial pathway. Ann. Oncol., 2010, 21(2), 263-268.
51. Guo, S.; Bezard, E.; Zhao, B. Protective effect of green tea polyphenols on the SH-SY5Y cells against 6-OHDA induced apoptosis through ROS-NO pathway. Free Radic. Biol. Med., 2005, 39(5), 682-695.
52. Ramiro-Puig, E.; Casadesús, G.; Lee, H.G.; Zhu, X.; McShea, A.; Perry, G.; Pérez-Cano, F.J.; Smith, M.A.; Castell, M. Neuroprotective effect of cocoa flavonoids on in vitro oxidative stress. Eur. J. Nutr., 2009, 48(1), 54-61.
53. Kalfon, L.; Youdim, M.B.; Mandel, S.A. Green tea polyphenol (-)epigallocatechin-3-gallate promotes the rapid protein kinase C-and proteasome-mediated degradation of Bad: implications for neuroprotection. J. Neurochem., 2007, 100(4), 992-1002.
54. Reznichenko, L.; Amit, T.; Youdim, M.B.; Mandel, S. Green tea polyphenol (-)-epigallocatechin-3-gallate induces neurorescue of long-term serum-deprived PC12 cells and promotes neurite outgrowth. J. Neurochem., 2005, 93(5), 1157-1167.
55. Singh, M.; Singh, R.; Bhui, K.; Tyagi, S.; Mahmood, Z.; Shukla, Y. Tea polyphenols induce apoptosis through mitochondrial pathway and by inhibiting nuclear factor-κB and Akt activation in human cervical cancer cells. Oncol. Res., 2011, 19(6), 245-257.
56. Li, G.X.; Chen, Y.K.; Hou, Z.; Xiao, H.; Jin, H.; Lu, G.; Lee, M.J.; Liu, B.; Guan, F.; Yang, Z.; Yu, A.; Yang, C.S. Pro-oxidative activities and dose-response relationship of (-)-epigallocatechin-3gallate in the inhibition of lung cancer cell growth: a comparative study in vivo and in vitro. Carcinogenesis, 2010, 31(5), 902-910.
57. Li, W.; Nie, S.; Yu, Q.; Xie, M. (-)-Epigallocatechin-3-gallate induces apoptosis of human hepatoma cells by mitochondrial pathways related to reactive oxygen species. J. Agric. Food Chem., 2009, 57(15), 6685-6691.
58. Noda, C.; He, J.; Takano, T.; Tanaka, C.; Kondo, T.; Tohyama, K.; Yamamura, H.; Tohyama, Y. Induction of apoptosis by epigallocatechin-3-gallate in human lymphoblastoid B cells. Biochem. Biophys. Res. Commun., 2007, 362(4), 951-957.
59. Yang, W.H.; Fong, Y.C.; Lee, C.Y.; Jin, T.R.; Tzen, J.T.; Li, T.M.; Tang, C.H. Epigallocatechin-3-gallate induces cell apoptosis of human chondrosarcoma cells through apoptosis signal-regulating kinase 1 pathway. J. Cell Biochem., 2011, 112(6), 1601-1611.
60. Ullah, M.F.; Ahmad, A.; Zubair, H.; Khan, H.Y.; Wang, Z.; Sarkar, F.H.; Hadi, S.M. Soy isoflavone genistein induces cell death in breast cancer cells through mobilization of endogenous copper ions and generation of reactive oxygen species. Mol. Nutr. Food Res., 2011, 55(4), 553-559.
61. Sánchez, Y.; Amrán, D.; de Blas, E.; Aller, P. Regulation of genistein-induced differentiation in human acute myeloid leukaemia cells (HL60, NB4) Protein kinase modulation and reactive oxygen species generation. Biochem. Pharmacol., 2009, 77(3), 384-396.
62. Sánchez, Y.; Amrán, D.; Fernández, C.; de Blas, E.; Aller, P. Genistein selectively potentiates arsenic trioxide-induced apoptosis in human leukemia cells via reactive oxygen species generation and activation of reactive oxygen species-inducible protein kinases (p38-MAPK, AMPK). Int. J. Cancer, 2008, 123(5), 1205-1214.
63. Russo, A.; Cardile, V.; Lombardo, L.; Vanella, L.; Acquaviva, R. Genistin inhibits UV light-induced plasmid DNA damage and cell growth in human melanoma cells. J. Nutr. Biochem., 2006, 17(2), 103-108.
64. Gutierrez-Zepeda, A.; Santell, R.; Wu, Z.; Brown, M.; Wu, Y.; Khan, I.; Link, C.D.; Zhao, B.; Luo, Y. Soy isoflavone glycitein protects against β amyloid-induced toxicity and oxidative stress in transgenic Caenorhabditis elegans. B.M.C. Neurosci., 2005, 6, 54.
65. Melchini, A.; Catania, S.; Stancanelli, R.; Tommasini, S.; Costa, C. Interaction of a functionalized complex of the flavonoid hesperetin with the AhR pathway and CYP1A1 expression: involvement in its protective effects against benzo[a]pyrene-induced oxidative stress in human skin. Cell Biol. Toxicol., 2011, 27(5), 371-379.
66. Li, S.; Dong, P.; Wang, J.; Zhang, J.; Gu, J.; Wu, X.; Wu, W.; Fei, X.; Zhang, Z.; Wang, Y.; Quan, Z.; Liu, Y. Icariin, a natural flavonol glycoside, induces apoptosis in human hepatoma SMMC7721 cells via a ROS/JNK-dependent mitochondrial pathway. Cancer Lett., 2010, 298(2), 222-230.
67. Sharma, V.; Joseph, C.; Ghosh, S.; Agarwal, A.; Mishra, M.K.; Sen, E. Kaempferol induces apoptosis in glioblastoma cells through oxidative stress. Mol. Cancer Ther., 2007, 6(9), 2544-2553.
68. Leung, H.W.; Lin, C.J.; Hour, M.J.; Yang, W.H.; Wang, M.Y.; Lee, H.Z. Kaempferol induces apoptosis in human lung non-small carcinoma cells accompanied by an induction of antioxidant enzymes. Food Chem. Toxicol., 2007, 45(10), 2005-2013.
69. Lee, S.; Kim, Y.J.; Kwon, S.; Lee, Y.; Choi, S.Y.; Park, J.; Kwon, H.J. Inhibitory effects of flavonoids on TNF-α-induced IL-8 gene expression in HEK 293 cells. BMB Rep., 2009, 42(5), 265-270.
70. Jeong, J.C.; Kim, M.S.; Kim, T.H.; Kim, Y.K. Kaempferol induces cell death through ERK and Akt-dependent down-regulation of XIAP and survivin in human glioma cells. Neurochem. Res., 2009, 34(5), 991-1001.
71. Choi, A.Y.; Choi, J.H.; Yoon, H.; Hwang, K.Y.; Noh, M.H.; Choe, W.; Yoon, K.S.; Ha, J.; Yeo, E.J.; Kang, I. Luteolin induces apoptosis through endoplasmic reticulum stress and mitochondrial dysfunction in Neuro-2a mouse neuroblastoma cells. Eur. J. Pharmacol., 2011, 668(1-2), 115-126.
72. Hwang, J.T.; Park, O.J.; Lee, Y.K.; Sung, M.J.; Hur, H.J.; Kim, M.S.; Ha, J.H.; Kwon, D.Y. Anti-tumor effect of luteolin is accompanied by AMP-activated protein kinase and nuclear factorκB modulation in HepG2 hepatocarcinoma cells. Int. J. Mol. Med., 2011, 28(1), 25-31.
73. Leung, H.W.; Kuo, C.L.; Yang, W.H.; Lin, C.H.; Lee, H.Z. Antioxidant enzymes activity involvement in luteolin-induced human lung squamous carcinoma CH27 cell apoptosis. Eur. J. Pharmacol., 2006, 534(1-3), 12-18.
74. Ju, W.; Wang, X.; Shi, H.; Chen, W.; Belinsky, S.A.; Lin, Y. A critical role of luteolin-induced reactive oxygen species in blockage of tumor necrosis factor-activated nuclear factor-κB pathway and sensitization of apoptosis in lung cancer cells. Mol. Pharmacol., 2007, 71(5), 1381-1388.
75. Harris, G.K.; Qian, Y.; Leonard, S.S.; Sbarra, D.C.; Shi, X. Luteolin and Chrysin differentially inhibit cyclooxygenase-2 expression and scavenge reactive oxygen species but similarly inhibit prostaglandin-E2 formation in RAW 264.7 cells. J. Nutr., 2006, 136(6), 1517-1521.
76. Shih, P.H.; Wu, C.H.; Yeh, C.T.; Yen, G.C. Protective effects of anthocyanins against amyloid β-peptide-induced damage in neuro2A cells. J. Agric. Food Chem., 2011, 59(5), 1683-1689.
77. Chow, J.M.; Huang, G.C.; Shen, S.C.; Wu, C.Y.; Lin, C.W.; Chen, Y.C. Differential apoptotic effect of wogonin and nor-wogonin via stimulation of ROS production in human leukemia cells. J. Cell Biochem., 2008, 103(5), 1394-1404.
78. Zhang, M.; Swarts, S.G.; Yin, L.; Liu, C.; Tian, Y.; Cao, Y.; Swarts, M.; Yang, S.; Zhang, S.B.; Zhang, K.; Ju, S.; Olek, D.J. Jr.; Schwartz, L.; Keng, P.C.; Howell, R.; Zhang, L.; Okunieff, P. Antioxidant properties of quercetin. Adv. Exp. Med. Biol., 2011, 701, 283-289.
79. Lee, Y.K.; Hwang, J.T.; Kwon, D.Y.; Surh, Y.J.; Park, O.J. Induction of apoptosis by quercetin is mediated through AMPKα1/ ASK1/p38 pathway. Cancer Lett., 2010, 292(2), 228-236.
80. Galluzzo, P.; Martini, C.; Bulzomi, P.; Leone, S.; Bolli, A.; Pallottini, V.; Marino, M. Quercetin-induced apoptotic cascade in cancer cells: antioxidant versus estrogen receptor α-dependent mechanisms. Mol. Nutr. Food Res., 2009, 53(6), 699-708.
81. Robaszkiewicz, A.; Balcerczyk, A.; Bartosz, G. Antioxidative and prooxidative effects of quercetin on A549 cells. Cell Biol. Int., 2007, 31(10), 1245-1250.
82. Chang, Y.F.; Chi, C.W.; Wang, J.J. Reactive oxygen species production is involved in quercetin-induced apoptosis in human hepatoma cells. Nutr. Cancer, 2006, 55(2), 201-209.
83. Min, K.; Ebeler, S.E. Quercetin inhibits hydrogen peroxide-induced DNA damage and enhances DNA repair in Caco-2 cells. Food Chem. Toxicol., 2009, 47(11), 2716-2722.
84. Soundararajan, R.; Wishart, A.D.; Rupasinghe, H.P.; Arcellana-Panlilio, M.; Nelson, C.M.; Mayne, M.; Robertson, G.S. Quercetin 3-glucoside protects neuroblastoma (SH-SY5Y) cells in vitro against oxidative damage by inducing sterol regulatory element-binding protein-2-mediated cholesterol biosynthesis. J. Biol. Chem., 2008, 283(4), 2231-2245.
85. Gong, G.; Qin, Y.; Huang, W.; Zhou, S.; Yang, X.; Li, D. Rutin inhibits hydrogen peroxide-induced apoptosis through regulating reactive oxygen species mediated mitochondrial dysfunction pathway in human umbilical vein endothelial cells. Eur. J. Pharmacol., 2010, 628(1-3), 27-35.
86. Yoon, J.H.; Lim, T.G.; Lee, K.M.; Jeon, A.J.; Kim, S.Y., Lee, K.W. Tangeretin reduces ultraviolet B (UVB)-induced cyclooxygenase-2 expression in mouse epidermal cells by blocking mitogen-activated protein kinase (MAPK) activation and reactive oxygen species (ROS) generation. J. Agric. Food Chem., 2011, 59(1), 222-228.
87. Adhikary, A.; Mohanty, S.; Lahiry, L.; Hossain, D.M.; Chakraborty, S.; Das, T. Theaflavins retard human breast cancer cell migration by inhibiting NF-κB via p53-ROS cross-talk. FEBS Lett., 2010, 584(1), 7-14.
88. Hsu, Y.L.; Hou, M.F.; Tsai, E.M.; Kuo, P.L. Tricetin, a dietary flavonoid, induces apoptosis through the reactive oxygen species/c-Jun NH(2)-terminal kinase pathway in human liver cancer cells. J. Agric. Food Chem., 2010, [Epub ahead of print].
89. Lin, C.C.; Kuo, C.L.; Lee, M.H.; Lai, K.C.; Lin, J.P.; Yang, J.S.; Yu, C.S.; Lu, C.C.; Chiang, J.H.; Chueh, F.S.; Chung, J.G. Wogonin triggers apoptosis in human osteosarcoma U-2 OS cells through the endoplasmic reticulum stress, mitochondrial dysfunction and caspase-3-dependent signaling pathways. Int. J. Oncol., 2011, 39(1), 217-224.
90. Yu, J.S.; Kim, A.K. Wogonin induces apoptosis by activation of ERK and p38 MAPKs signaling pathways and generation of reactive oxygen species in human breast cancer cells. Mol. Cells, 2011, 31(4), 327-335.
91. Yang, L.; Zheng, X.L.; Sun, H.; Zhong, Y.J.; Wang, Q.; He, H.N.; Shi, X.W.; Zhou, B.; Li, J.K.; Lin, Y.; Zhang, L.; Wang, X. Catalase suppression-mediated H(2)O(2) accumulation in cancer cells by wogonin effectively blocks tumor necrosis factor-induced NF-κB activation and sensitizes apoptosis. Cancer Sci., 2011, 102(4):870-876.
92. Virchow, R. Aetiologie der neoplastischen Geschwülste/Pathogenie der neoplastischen Geschwülste. In: Die Krankhaften Geschwülste. Berlin: Verlag von August Hirschwald, 1863, 57-101.
93. Coussens, L.M.; Werb, Z. Inflammation and cancer. Nature, 2002, 420(6917), 860-867.
94. Leonardi, T.; Vanamala, J.; Taddeo, S.S.; Davidson, L.A.; Murphy, M.E.; Patil, B.S.; Wang, N.; Carroll, R.J.; Chapkin, R.S.; Lupton, J.R.; Turner, N.D. Apigenin and naringenin suppress colon carcinogenesis through the aberrant crypt stage in azoxymethanetreated rats. Exp. Biol. Med. (Maywood), 2010, 235(6), 710-717.
95. Ashokkumar, P.; Sudhandiran, G. Luteolin inhibits cell proliferation during Azoxymethane-induced experimental colon carcinogenesis via Wnt/ β-catenin pathway. Invest. New Drugs, 2011, 29(2), 273-284.
96. Oyama, T.; Yasui, Y.; Sugie, S.; Koketsu, M.; Watanabe, K.; Tanaka, T. Dietary tricin suppresses inflammation-related colon carcinogenesis in male Crj: CD-1 mice. Cancer Prev. Res (Phila)., 2009, 2(12), 1031-1038.
97. Miyamoto, S.; Yasui, Y.; Ohigashi, H.; Tanaka, T.; Murakami, A. Dietary flavonoids suppress azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice. Chem. Biol. Interact., 2010, 183(2), 276-283.
98. Raju, J.; Bielecki, A.; Caldwell, D.; Lok, E.; Taylor, M.; Kapal, K.; Curran, I.; Cooke, G.M.; Bird, R.P.; Mehta, R. Soy isoflavones modulate azoxymethane-induced rat colon carcinogenesis exposed pre-and postnatally and inhibit growth of DLD-1 human colon adenocarcinoma cells by increasing the expression of estrogen receptor-β. J. Nutr., 2009, 139(3), 474-481.
99. Shimizu, M.; Shirakami, Y.; Sakai, H.; Adachi, S.; Hata, K.; Hirose, Y.; Tsurumi, H.;Tanaka, T.; Moriwaki, H. (-)-Epigallocatechin gallate suppresses azoxymethane-induced colonic premalignant lesions in male C57BL/KsJ-db/db mice. Cancer Prev. Res (Phila)., 2008, 1(4), 298-304.
100. Miyamoto, S.; Yasui, Y.; Tanaka, T.; Ohigashi, H.; Murakami, A. Suppressive effects of nobiletin on hyperleptinemia and colitis-related colon carcinogenesis in male ICR mice. Carcinogenesis, 2008, 29(5), 1057-1063.
101. Murillo, G.; Hirschelman, W.H.; Ito, A.; Moriarty, R.M.; Kinghorn, A.D.; Pezzuto, J.M.; Mehta, R.G. Zapotin, a phytochemical present in a Mexican fruit, prevents colon carcinogenesis. Nutr. Cancer, 2007, 57(1), 28-37.
102. Asano, N.; Kuno, T.; Hirose, Y.; Yamada, Y.; Yoshida, K.; Tomita, H.; Nakamura, Y.; Mori, H. Preventive effects of a flavonoid myricitrin on the formation of azoxymethane-induced premalignant lesions in colons of rats. Asian Pac. J. Cancer Prev., 2007, 8(1): 73-76.
103. Sengupta, A.; Ghosh, S.; Das, R.K.; Bhattacharjee, S.; Bhattacharya, S. Chemopreventive potential of diallylsulfide, lycopene and theaflavin during chemically induced colon carcinogenesis in rat colon through modulation of cyclooxygenase2 and inducible nitric oxide synthase pathways. Eur. J. Cancer Prev., 2006, 15(4), 301-305.
104. Lala, G.; Malik, M.; Zhao, C.; He, J.; Kwon, Y.; Giusti, M.M.; Magnuson, B.A. Anthocyanin-rich extracts inhibit multiple biomarkers of colon cancer in rats. Nutr. Cancer, 2006, 54(1), 84-93.
105. Miyamoto, S.; Kohno, H.; Suzuki, R.; Sugie, S.; Murakami, A.; Ohigashi, H.; Tanaka, T. Preventive effects of chrysin on the development of azoxymethane-induced colonic aberrant crypt foci in rats. Oncol. Rep., 2006, 15(5):1169-1173.
106. Nomoto, H.; Iigo, M.; Hamada, H.; Kojima, S.; Tsuda, H. Chemoprevention of colorectal cancer by grape seed proanthocyanidin is accompanied by a decrease in proliferation and increase in apoptosis. Nutr. Cancer, 2004, 49(1), 81-88.
107. Takahashi, T.; Takasuka, N.; Iigo, M.; Baba, M.; Nishino, H.; Tsuda, H.; Okuyama, T. Isoliquiritigenin, a flavonoid from licorice, reduces prostaglandin E2 and nitric oxide, causes apoptosis, and suppresses aberrant crypt foci development. Cancer Sci., 2004, 95(5), 448-453.
108. Matsunaga, K.; Yoshimi, N.; Shimoi, K.; Yamada, Y.; Katayama, M.; Sakata, K.; Kumo, T.; Yoshida, K.; Qiao, Z.; Kinae, N.; Mori, H. Inhibitory Effects of Dietary Monoglucosyl-rutin on Azoxymethane-induced Colon Carcinogenesis in Rats. Asian Pac. J. Cancer Prev., 2000, 1(3), 211-216.
109. Murillo, G.; Kosmeder, J.W. II; Pezzuto, J.M.; Mehta, R.G. Deguelin suppresses the formation of carcinogen-induced aberrant crypt foci in the colon of CF-1 mice. Int. J. Cancer, 2003, 104(1), 7-11.
110. Tanaka, T.; Kawabata, K.; Honjo, S.; Kohno, H.; Murakami, M.; Shimada, R.; Matsunaga, K.; Yamada, Y.; Shimizu, M. Inhibition of azoxymethane-induced aberrant crypt foci in rats by natural compounds, caffeine, quercetin and morin. Oncol. Rep., 1999, 6(6), 1333-1340.
111. Tanaka, T.; Makita, H.; Kawabata, K.; Mori, H.; Kakumoto, M.; Satoh, K.; Hara, A.; Sumida, T.; Tanaka, T.; Ogawa, H. Chemoprevention of azoxymethane-induced rat colon carcinogenesis by the naturally occurring flavonoids, diosmin and hesperidin. Carcinogenesis, 1997, 18(5), 957-965.
112. Deschner, E.E.; Ruperto, J.; Wong, G.; Newmark, H.L. Quercetin and rutin as inhibitors of azoxymethanol-induced colonic neoplasia. Carcinogenesis, 1991, 12(7), 1193-1196.
113. Meeran, S.M.; Vaid, M.; Punathil, T.; Katiyar, S.K. Dietary grape seed proanthocyanidins inhibit 12-O-tetradecanoyl phorbol-13acetate-caused skin tumor promotion in 7,12-dimethylbenz[a] anthracene-initiated mouse skin, which is associated with the inhibition of inflammatory responses. Carcinogenesis, 2009, 30(3), 520-528.
114. Pan, M.H.; Lai, C.S.; Wang, Y.J.; Ho, C.T. Acacetin suppressed LPS-induced up-expression of iNOS and COX-2 in murine macrophages and TPA-induced tumor promotion in mice. Biochem. Pharmacol., 2006, 72(10), 1293-1303.
115. Ueda, H.; Yamazaki, C.; Yamazaki, M. Inhibitory effect of Perilla leaf extract and luteolin on mouse skin tumor promotion. Biol. Pharm. Bull., 2003, 26(4), 560-563.
116. Wei, H.; Bowen, R.; Zhang, X.; Lebwohl, M. Isoflavone genistein inhibits the initiation and promotion of two-stage skin carcinogenesis in mice. Carcinogenesis, 1998, 19(8), 1509-1514.
117. Yamamoto, S.; Aizu, E.; Jiang, H.; Nakadate, T.; Kiyoto, I.; Wang, J.C.; Kato, R. The potent anti-tumor-promoting agent isoliquiritigenin. Carcinogenesis, 1991, 12(2), 317-323.
118. Yasukawa, K.; Takido, M.; Takeuchi, M.; Sato, Y.; Nitta, K.; Nakagawa, S. Inhibitory effects of flavonol glycosides on 12-Otetradecanoylphorbol-13-acetate-induced tumor promotion. Chem. Pharm. Bull. (Tokyo), 1990, 38(3), 774-776.
119. Wei, H.; Tye, L.; Bresnick, E.; Birt, D.F. Inhibitory effect of apigenin, a plant flavonoid, on epidermal ornithine decarboxylase and skin tumor promotion in mice. Cancer Res., 1990, 50(3), 499-502.
120. Ide, H.; Tokiwa, S.; Sakamaki, K.; Nishio, K.; Isotani, S.; Muto, S.; Hama, T.; Masuda, H.; Horie, S. Combined inhibitory effects of soy isoflavones and curcumin on the production of prostate-specific antigen. Prostate, 2010, 70(10), 1127-1133.
121. Bobe, G.; Albert, P.S.; Sansbury, L.B.; Lanza, E.; Schatzkin, A.; Colburn, N.H.; Cross, A.J. Interleukin-6 as a potential indicator for prevention of high-risk adenoma recurrence by dietary flavonols in the polyp prevention trial. Cancer Prev. Res. (Phila), 2010, 3(6), 764-775.
122. Ko, K.P.; Park, S.K.; Park, B.; Yang, J.J.; Cho, L.Y.; Kang, C.; Kim, C.S.; Gwack, J.; Shin, A.; Kim, Y.; Kim, J.; Yang, H.K.; Kang, D.; Chang, S.H.; Shin, H.R.; Yoo, K.Y. Isoflavones from phytoestrogens and gastric cancer risk: a nested case-control study within the Korean Multicenter Cancer Cohort. Cancer Epidemiol. Biomarkers Prev., 2010, 19(5), 1292-1300.
123. McLarty, J.; Bigelow, R.L.; Smith, M.; Elmajian, D.; Ankem, M.; Cardelli, J.A. Tea polyphenols decrease serum levels of prostate-specific antigen, hepatocyte growth factor, and vascular endothelial growth factor in prostate cancer patients and inhibit production of hepatocyte growth factor and vascular endothelial growth factor in vitro. Cancer Prev. Res. (Phila), 2009, 2(7), 673-682.
124. Iwasaki, M.; Hamada, G.S.; Nishimoto, I.N.; Netto, M.M.; Motola, J. Jr,; Laginha, F.M.; Kasuga, Y.; Yokoyama, S.; Onuma, H.; Nishimura, H.; Kusama, R.; Kobayashi, M.; Ishihara, J.; Yamamoto, S.; Hanaoka, T.; Tsugane, S. Dietary isoflavone intake and breast cancer risk in case-control studies in Japanese, Japanese Brazilians, and non-Japanese Brazilians. Breast Cancer Res. Treat., 2009, 116(2), 401-411.
125. Rossi, M.; Negri, E.; Talamini, R.; Bosetti, C.; Parpinel, M.; Gnagnarella, P.; Franceschi, S.; Dal Maso, L.; Montella, M.; Giacosa, A.; La Vecchia, C. Flavonoids and colorectal cancer in Italy. Cancer Epidemiol. Biomarkers Prev., 2006, 15(8), 1555-1558.
126. Hirvonen, T.; Virtamo, J.; Korhonen, P.; Albanes, D.; Pietinen, P. Flavonol and flavone intake and the risk of cancer in male smokers (Finland). Cancer Causes Control, 2001, 12(9), 789-796.
127. Bobe, G.; Peterson, J.J.; Gridley, G.; Hyer, M.; Dwyer, J.T.; Brown, L.M. Flavonoid consumption and esophageal cancer among black and white men in the United States. Int. J. Cancer, 2009, 125(5), 1147-1154.
128. Wang M L.; Lee M I.M.; Zhang, S.M.; Blumberg, J.B.; Buring, J.E.; Sesso, H.D. Dietary intake of selected flavonols, flavones, and flavonoid-rich foods and risk of cancer in middle-aged and older women. Am. J. Clin. Nutr., 2009, 89(3), 905-912.
129. Adams, K.F.; Lampe, P.D.; Newton, K.M.; Ylvisaker, J.T.; Feld, A.; Myerson, D.; Emerson, S.S.; White, E.; Potter, J.D.; Lampe, J.W. Soy protein containing isoflavones does not decrease colorectal epithelial cell proliferation in a randomized controlled trial. Am. J. Clin. Nutr., 2005, 82(3), 620-626.
130. Kiessling, R.; Klein, E.; Wigzell, H. Natural killer cells in the mouse. I. Cytotoxic cells with specificity for mouse Moloney leukemia cells. Specificity and distribution according to genotype. Eur. J. Immunol., 1975, 5(2), 112-117.
131. Sutlu, T.; Alici, E. Natural killer cell-based immunotherapy in cancer: current insights and future prospects. J. Intern. Med., 2009, 266(2), 154-181.
132. Guruvayoorappan, C.; Kuttan G. Amentoflavone, a biflavonoid from Biophytum sensitivum augments lymphocyte proliferation, natural killer cell and antibody dependent cellular cytotoxicity through enhanced production of IL-2 and IFN-γ and restrains serum sialic acid and γ glutamyl transpeptidase production in tumor -bearing animals. J. Exp. Ther. Oncol., 2007, 6(4), 285-295.
133. Chang, S.L.; Yeh, H.H.; Lin, Y.S.; Chiang, Y.M.; Wu, T.K.; Yang, W.C. The effect of centaurein on interferon-γ expression and Listeria infection in mice. Toxicol Appl Pharmacol., 2007, 219(1), 54-61.
134. Beaumont, D.M.; Mark, T.M. Jr.; Hills, R.; Dixon, P.; Veit, B.; Garrett, N. The effects of chrysin, a Passiflora incarnata extract, on natural killer cell activity in male Sprague-Dawley rats undergoing abdominal surgery. A.A.N.A. J., 2008, 76(2), 113-117.
135. Pár, A.; Szekeres-Bartho, J.; Pácsa, S.; Jávor, T. Effect of cianidanol on natural killer cell activity in patients with chronic B virus hepatitis. Int. J. Clin. Pharmacol. Res., 1987, 7(4), 301-306.
136. Ikeda, Y.; Kawakami, K.; Sato, I.; Tajima, S.; Ito, K.; Nose, T. Effect of cianidanol (KB-53) on the activity of mouse natural killer cells. J. Pharmacobiodyn., 1984, 7(1), 21-23.
137. Bub, A.; Watzl, B.; Blockhaus, M.; Briviba, K.; Liegibel, U.; Müller, H.; Pool-Zobel, B.L.; Rechkemmer, G. Fruit juice consumption modulates antioxidative status, immune status and DNA damage. J. Nutr. Biochem., 2003, 14(2), 90-98.
138. Zheng, W.; Gao, X.; Chen, C.; Tan, R. Total flavonoids of Daphne genkwa root significantly inhibit the growth and metastasis of Lewis lung carcinoma in C57BL6 mice. Int. Immunopharmacol., 2007, 7(2), 117-127.
139. Salup, R.R.; Sicker, D.C.; Wolmark, N.; Herberman, R.B.; Hakala, T.R. Chemoimmunotherapy of metastatic murine renal cell carcinoma using flavone acetic acid and interleukin 2. J. Urol., 1992, 147(4), 1120-1123.
140. Damia, G.; Tagliabue, G.; Allavena, P.; D'Incalci, M. Flavone acetic acid antitumour activity against a mouse pancreatic adenocarcinoma is mediated by natural killer cells. Cancer Immunol. Immunother., 1990, 32(4), 241-244.
141. Jiang, X.; Patterson, N.M.; Ling, Y.; Xie, J.; Helferich, W.G.; Shapiro, D.J. Low concentrations of the soy phytoestrogen genistein induce proteinase inhibitor 9 and block killing of breast cancer cells by immune cells. Endocrinology, 2008, 149(11), 5366-5373.
142. Guo, T.L.; Chi, R.P.; Hernandez, D.M.; Auttachoat, W.; Zheng, J.F. Decreased 7,12-dimethylbenz[a]anthracene-induced carcinogenesis coincides with the induction of antitumor immunities in adult female B6C3F1 mice pretreated with genistein. Carcinogenesis, 2007, 28(12), 2560-2566.
143. Zhang, Y.; Song, T.T.; Cunnick, J.E.; Murphy, P.A.; Hendrich, S. Daidzein and genistein glucuronides in vitro are weakly estrogenic and activate human natural killer cells at nutritionally relevant concentrations. J. Nutr., 1999, 129(2), 399-405.
144. He, W.; Sun, H.; Yang, B.; Zhang, D.; Kabelitz, D. Immunoregulatory effects of the herba Epimediia glycoside icariin. Arzneimittelforschung, 1995, 45(8), 910-913.
145. Zhang, X.Y.; Li, W.G.; Wu, Y.J.; Zheng, T.Z.; Li, W.; Qu, S.Y.; Liu, N.F. Proanthocyanidin from grape seeds potentiates anti-tumor activity of doxorubicin via immunomodulatory mechanism. Int. Immunopharmacol., 2005, 5(7-8), 1247-1257.
146. Bae, J.H.; Kim, J.Y.; Kim, M.J.; Chang, S.H.; Park, Y.S.; Son, C.H.; Park, S.J.; Chung, J.S.; Lee, E.Y.; Kim, S.H.; Kang, C.D. Quercetin enhances susceptibility to NK cell-mediated lysis of tumor cells through induction of NKG2D ligands and suppression of HSP70. J. Immunother., 2010, 33(4), 391-401.
147. Heinz, S.A.; Henson, D.A.; Nieman, D.C.; Austin, M.D.; Jin, F. A 12-week supplementation with quercetin does not affect natural killer cell activity, granulocyte oxidative burst activity or granulocyte phagocytosis in female human subjects. Br. J. Nutr., 2010, 104(6), 849-857.
148. Tang, N.Y.; Yang, J.S.; Chang, Y.H.; Lu, H.F.; Hsia, T.C.; Lin, W.C.; Chung, J.G. Effects of wogonin on the levels of cytokines and functions of leukocytes associated with NF-κB expression in Sprague-Dawley rats. In Vivo, 2006, 20(4), 527-532.
149. Lv, P.; Huang, X.W.; Lv, Q.J. [Advances in studies on absorption, distribution, metabolism of flavonoids]. Zhongguo Zhong Yao Za Zhi, 2007, 32(19), 1961-1964.
150. Walle, T. Methoxylated flavones, a superior cancer chemopreventive flavonoids subclass? Semin. Cancer Biol., 2007, 17(5), 354-362.
151. Li, Y.; Wei, X.; Xu, H.; Huang, X.; Yao, Z. Insecticidal ingredients from yam bean (Pachyrrhizus erosus) seeds and their insecticidal toxicity. Kunchong Xuebao, 2009, 52(5), 514-521.
152. Guo, H.; Li, Y.; Xiao, F.; Wen, L.; Li, J. Growth inhibition ingredients isolated from Poloygonum limicola stems against larvae of Herse convolvuli. Hunan Nongye Daxue Xuebao, 2008, 34(2), 221-225.
153. Crawford, D.J.; Smith, E.B. Leaf flavonoid chemistry of North American Coreopsis (Compositae): intra-and intersectional variation. Botanical Gazette (Chicago), 1983, 144(4), 577-583.
154. Santos, L.S.; Correa, M.J.C.; Campos, L.M.O.; Andrade, M.A. Constituents from the leaves of Virola michelli. Fitoterapia, 1996, 67(6), 555-556.
155. Cavalcante, S.H.; Fernandes, D.; Paulino Fo, H.F.; Yoshida, M.; Gottlieb, O.R. The chemistry of Brazilian Myristicaceae. Part 26. Lignoids from the fruit of three Virola species. Phytochemistry, 1985, 24(8), 1865-1866.
156. Popravko, S.A.; Gurevich, A.I.; Kolosov, M.N. Flavonoid components of propolis. Khimiya Prirodnykh Soedinenii, 1969, 5(6), 476-482.
157. Mayer, R.A. β-Hydroxychalcone from Leptospermum scoparium. Planta Med., 1993, 59(3), 269-271.
158. Sawasdee, P.;Sabphon, C.;Sitthiwongwanit, D.;Kokpol, U. Anticholinesterase activity of 7-methoxyflavones isolated from Kaempferia parviflora. Phytother. Res., 2009, 23(12), 1792-1794.
159. Chen, J.; Montanari, A.M.; Widmer, W.W. two new polymethoxylated flavones, a class of compounds with potential anticancer activity, isolated from cold pressed dancy tangerine peel oil solids. J. Agric.Food Chem., 1997, 45(2), 364-368.
160. Gabor, M. In: Handbook of Experimental Pharmacology vol 50 (II) Vane, J.R.; Ferreira, S.H. (eds), Springer Verlag, New York, 1979, p. 698.
161. Maiti, A.; Cuendet, M.; Kondratyuk, T.; Croy, V.L.; Pezzuto, J.M.; Cushman, M. Synthesis and cancer chemopreventive activity of zapotin, a natural product from Casimiroa edulis. J. Med. Chem., 2007, 50(2), 350-355.
162. Matsubara, Y.; Kumamoto, H.; Iizuka, Y.; Murakami, T.; Okamoto, K.; Miyake, H.; Yokoi, K. Structure and Hypotensive Effect of Flavonoid Glycosides in Citrus unshiu Peelings. Agric. Biol. Chem., 1985, 49(4), 909-914.
163. Sugiyama, S.; Umehara, K.; Kuroyanagi, M.; Ueno, A.; Taki, T. Studies on the differentiation inducers of myeloid leukemic cells from Citrus species. Chem. Pharm. Bull. (Tokyo), 1993,41(4), 714-719.
164. Kumamoto, H.; Matsubara, Y.; Iizuka, Y.; Okamoto, K.; Yokoi, K. Structure and Hypotensive Effect of Flavonoid Glycosides in Orange (Citrus sinensis OSBECK) Peelings. Agric. Biol. Chem., 1986, 50(3), 781-783.
165. Li, S.; Lo, C.Y.; Ho, C.T. Hydroxylated polymethoxyflavones and methylated flavonoids in sweet orange (Citrus sinensis) peel. J. Agric. Food Chem., 2006, 54(12), 4176-4185.
166. Ahmad, F.; Bakar, S.A.; Ibrahim, A.Z.; Read, R.W. Constituents of the leaves of Piper caninum. Planta Med., 1997, 63(2), 193-194.
167. Tang, M.X.; Ogawa, K.; Asamoto, M.; Chewonarin, T.; Suzuki, S.; Tanaka, T.; Shirai, T. Effects of nobiletin on PhIP-induced prostate and colon carcinogenesis in F344 rats. Nutr. Cancer., 2011, 63(2), 227-233.
168. Lee, Y.C.; Cheng, T.H.; Lee, J.S.; Chen, J.H.; Liao, Y.C.; Fong, Y.; Wu, C.H.; Shih, Y.W. Nobiletin, a citrus flavonoid, suppresses invasion and migration involving FAK/PI3K/Akt and small GTPase signals in human gastric adenocarcinoma AGS cells. Mol. Cell Biochem., 2011, 347(1-2), 103-115.
169. Kim, H.; Moon, J.Y.; Mosaddik, A.; Cho, S.K. Induction of apoptosis in human cervical carcinoma HeLa cells by polymethoxylated flavone-rich Citrus grandis Osbeck (Dangyuja) leaf extract. Food Chem. Toxicol., 2010, 48(8-9), 2435-2442.
170. Ishii, K.; Tanaka, S.; Kagami, K.; Henmi, K.; Toyoda, H.; Kaise, T.; Hirano, T. Effects of naturally occurring polymethyoxyflavonoids on cell growth, p-glycoprotein function, cell cycle, and apoptosis of daunorubicin-resistant T lymphoblastoid leukemia cells. Cancer Invest., 2010, 28(3), 220-229.
171. Wang, Y.; Su, M.; Yin, J.; Zhang, H. Effect of nobiletin on K562 cells xenograft in nude mice. Zhongguo Zhong Yao Za Zhi, 2009, 34(11), 1410-1414.
172. Luo, G.; Zeng, Y.; Zhu, L.; Zhang, Y.X.; Zhou, L.M. Inhibition effect and its mechanism of nobiletin on proliferation of lung cancer cells. Sichuan Da Xue Xue Bao Yi Xue Ban, 2009, 40(3), 449-453.
173. Xiao, H.; Yang, C.S.; Li, S.; Jin, H.; Ho, C.T.; Patel, T. Monodemethylated polymethoxyflavones from sweet orange (Citrus sinensis) peel inhibit growth of human lung cancer cells by apoptosis. Mol. Nutr. Food Res., 2009, 53(3), 398-406.
174. Lai, C.S.; Li, S.; Chai, C.Y.; Lo, C.Y.; Dushenkov, S.; Ho, C.T.; Pan, M.H.; Wang, Y.J. Anti-inflammatory and antitumor promotional effects of a novel urinary metabolite, 3',4'-didemethylnobiletin, derived from nobiletin. Carcinogenesis, 2008, 29(12), 2415-2424.
175. Luo, G.; Guan, X.; Zhou, L. Apoptotic effect of citrus fruit extract nobiletin on lung cancer cell line A549 in vitro and in vivo. Cancer Biol.Ther., 2008, 7(6), 966-973.
176. Akao, Y.; Itoh, T.; Ohguchi, K.; Iinuma, M.; Nozawa, Y. Interactive effects of polymethoxy flavones from Citrus on cell growth inhibition in human neuroblastoma SH-SY5Y cells. Bioorg. Med. Chem., 2008, 16(6), 2803-2810.
177. Miyata Y, Sato T, Imada K, Dobashi A, Yano M, Ito A. A citrus polymethoxyflavonoid, nobiletin, is a novel MEK inhibitor that exhibits antitumor metastasis in human fibrosarcoma HT-1080 cells. Biochem Biophys. Res. Commun., 2008, 366(1), 168-173.
178. Yoon, H.S.; Lee, S.R.; Ko, H.C.; Choi, S.Y.; Park, J.G.; Kim, J.K.; Kim, S.J. Involvement of extracellular signal-regulated kinase in nobiletin-induced melanogenesis in murine B16/F10 melanoma cells. Biosci. Biotechnol. Biochem., 2007, 71(7), 1781-1784.
179. Ohtani, H.; Ikegawa, T.; Honda, Y.; Kohyama, N.; Morimoto, S.; Shoyama, Y.; Juichi, M.; Naito, M.; Tsuruo, T.; Sawada, Y. Effects of various methoxyflavones on vincristine uptake and multidrug resistance to vincristine in P-gp-overexpressing K562/ADM cells. Pharm. Res., 2007, 24(10), 1936-1943.
180. Zhang, C.; Lu, Y.; Tao, L.; Tao, X.; Su, X.; Wei, D. Tyrosinase inhibitory effects and inhibition mechanisms of nobiletin and hesperidin from citrus peel crude extracts. J. Enzyme Inhib. Med. Chem., 2007, 22(1), 91-98.
181. Tang, M.; Ogawa, K.; Asamoto, M.; Hokaiwado, N.; Seeni, A.; Suzuki, S.; Takahashi, S.; Tanaka, T.; Ichikawa, K.; Shirai, T. Protective effects of citrus nobiletin and auraptene in transgenic rats developing adenocarcinoma of the prostate (TRAP) and human prostate carcinoma cells. Cancer Sci., 2007, 98(4), 471-477.
182. Morley, K.L.; Ferguson, P.J.; Koropatnick, J. Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells. Cancer Lett., 2007, 251(1), 168-178.
183. Kawabata, K.; Murakami, A.; Ohigashi, H. Nobiletin, a citrus flavonoid, down-regulates matrix metalloproteinase-7 (matrilysin) expression in HT-29 human colorectal cancer cells. Biosci. Biotechnol. Biochem., 2005, 69(2), 307-314.
184. Miyata, Y.; Sato, T.; Yano, M.; Ito, A. Activation of protein kinase C βII/epsilon-c-Jun NH2-terminal kinase pathway and inhibition of mitogen-activated protein/extracellular signal-regulated kinase 1/2 phosphorylation in antitumor invasive activity induced by the polymethoxy flavonoid, nobiletin. Mol. Cancer Ther., 2004, 3(7), 839-847.
185. Sato, T.; Koike, L.; Miyata, Y.; Hirata, M.; Mimaki, Y.; Sashida, Y.; Yano, M.; Ito, A. Inhibition of activator protein-1 binding activity and phosphatidylinositol 3-kinase pathway by nobiletin, a polymethoxy flavonoid, results in augmentation of tissue inhibitor of metalloproteinases-1 production and suppression of production of matrix metalloproteinases-1 and -9 in human fibrosarcoma HT1080 cells. Cancer Res., 2002, 62(4), 1025-1029.
186. Murakami, A.; Nakamura, Y.; Ohto, Y.; Yano, M.; Koshiba, T.; Koshimizu, K.; Tokuda, H.; Nishino, H.; Ohigashi, H. Suppressive effects of citrus fruits on free radical generation and nobiletin, an anti-inflammatory polymethoxyflavonoid. Biofactors, 2000, 12(14), 187-192.
187. Kandaswami, C.; Perkins, E.; Soloniuk, D.S.; Drzewiecki, G.; Middleton, E. Jr. Antiproliferative effects of citrus flavonoids on a human squamous cell carcinoma in vitro. Cancer Lett., 1991, 56(2), 147-152.
188. Cheng, Z.; Surichan, S.; Ruparelia, K.; Arroo, R.; Boarder, M.R. Tangeretin and its metabolite 4'-hydroxytetramethoxyflavone attenuate EGF-stimulated cell cycle progression in hepatocytes; role of inhibition at the level of mTOR/p70S6K. Br. J. Pharmacol., 2011, 162(8), 1781-1791.
189. Arafa El-S.A.; Zhu, Q.; Barakat, B.M.; Wani, G.; Zhao, Q.; El-Mahdy, M.A.; Wani, A.A. Tangeretin sensitizes cisplatin-resistant human ovarian cancer cells through downregulation of phosphoinositide 3-kinase/Akt signaling pathway. Cancer Res., 2009, 69(23), 8910-8917.
190. Chen, K.H.; Weng, M.S.; Lin, J.K. Tangeretin suppresses IL-1βinduced cyclooxygenase (COX)-2 expression through inhibition of p38 MAPK, JNK, and AKT activation in human lung carcinoma cells. Biochem. Pharmacol., 2007, 73(2), 215-227.
191. Van Slambrouck, S.; Parmar, V.S.; Sharma, S.K.; De Bondt, B.; Foré, F.; Coopman, P.; Vanhoecke, B.W.; Boterberg, T.; Depypere, H.T.; Leclercq, G.; Bracke, M.E. Tangeretin inhibits extracellularsignal-regulated kinase (ERK) phosphorylation. FEBS Lett., 2005, 579(7), 1665-1669.
192. Yáñez, J.; Vicente, V.; Alcaraz, M.; Castillo, J.; Benavente-García, O.; Canteras, M.; Teruel, J.A. Cytotoxicity and antiproliferative activities of several phenolic compounds against three melanocytes cell lines: relationship between structure and activity. Nutr. Cancer, 2004, 49(2), 191-199.
193. Pan, M.H.; Chen, W.J.; Lin-Shiau, S.Y.; Ho, C.T.; Lin, J.K. Tangeretin induces cell-cycle G1 arrest through inhibiting cyclin dependent kinases 2 and 4 activities as well as elevating Cdk inhibitors p21 and p27 in human colorectal carcinoma cells. Carcinogenesis, 2002, 23(10), 1677-1684.
194. Rooprai, H.K.; Kandanearatchi, A.; Maidment, S.L.; Christidou, M.; Trillo-Pazos, G.; Dexter, D.T.; Rucklidge, G.J.; Widmer, W.; Pilkington, G.J. Evaluation of the effects of swainsonine, captopril, tangeretin and nobiletin on the biological behaviour of brain tumour cells in vitro. Neuropathol, Appl. Neurobiol., 2001, 27(1), 29-39.
195. Ikegawa, T.; Ushigome, F.; Koyabu, N.; Morimoto, S.; Shoyama, Y.; Naito, M.; Tsuruo, T.; Ohtani, H.; Sawada, Y. Inhibition of P-glycoprotein by orange juice components, polymethoxyflavones in adriamycin-resistant human myelogenous leukemia (K562/ADM) cells. Cancer Lett., 2000, 160(1), 21-28.
196. Breinholt, V.; Lauridsen, S.T.; Dragsted, L.O. Differential effects of dietary flavonoids on drug metabolizing and antioxidant enzymes in female rat. Xenobiotica, 1999, 29(12), 1227-1240.
197. Kawaii, S.; Tomono, Y.; Katase, E.; Ogawa, K.; Yano, M. Antiproliferative activity of flavonoids on several cancer cell lines. Biosci. Biotechnol. Biochem., 1999, 63(5), 896-899.
198. Mak, N.K.; Wong-Leung, Y.L.; Chan, S.C.; Wen, J.; Leung, K.N.; Fung, M.C. Isolation of anti-leukemia compounds from Citrus reticulata. Life Sci., 1996, 58(15), 1269-1276.
199. Hirano, T.; Abe, K.; Gotoh, M.; Oka, K. Citrus flavone tangeretin inhibits leukaemic HL-60 cell growth partially through induction of apoptosis with less cytotoxicity on normal lymphocytes. Br. J. Cancer, 1995, 72(6), 1380-1388.
200. Kandaswami, C.; Perkins, E.; Drzewiecki, G.; Soloniuk, D.S.; Middleton, E. Jr. Differential inhibition of proliferation of human squamous cell carcinoma, gliosarcoma and embryonic fibroblast-like lung cells in culture by plant flavonoids. Anticancer Drugs, 1992, 3(5), 525-530.
201. Bracke, M.E.; Vyncke, B.M.; Van Larebeke, N.A.; Bruyneel, E.A.; De Bruyne, G.K.; De Pestel, G.H.; De Coster, W.J.; Espeel, M.F.; Mareel, M.M. The flavonoid tangeretin inhibits invasion of MO4 mouse cells into embryonic chick heart in vitro. Clin. Exp. Metastasis, 1989, 7(3), 283-300.
202. Cuendet, M.; Oteham, C.P.; Maiti, A.; Craig, B.A.; Cushman, M.; Moon, R.C.; Pezzuto, J.M. Zapotin prevents mouse skin tumorigenesis during the stages of initiation and promotion. Anticancer Res., 2008, 28(6A), 3705-3709.
203. Mata-Greenwood, E.; Ito, A.; Westenburg, H.; Cui, B.; Mehta, R.G.; Kinghorn, A.D.; Pezzuto, J.M. Discovery of novel inducers of cellular differentiation using HL-60 promyelocytic cells. Anticancer Res., 2001, 21(3B), 1763-1770.
204. Dong, Y.; Ji, G.; Cao, A.; Shi, J.; Shi, H.; Xie, J.; Wu, D. Effects of sinensetin on proliferation and apoptosis of human gastric cancer AGS cells. Zhongguo Zhong Yao Za Zhi, 2011, 36(6), 790-794.
205. Androutsopoulos, V.P.; Ruparelia, K.; Arroo, R.R.; Tsatsakis, A.M.; Spandidos, D.A. CYP1-mediated antiproliferative activity of dietary flavonoids in MDA-MB-468 breast cancer cells. Toxicology, 2009, 264(3), 162-170.
206. Leonarduzzi, G.; Testa, G.; Sottero, B.; Gamba, P.; Poli, G. Design and development of nanovehicle-based delivery systems for preventive or therapeutic supplementation with flavonoids. Curr. Med. Chem., 2010, 17(1), 74-95.
207. Blanco, E.; Hsiao, A.; Mann, A.P.; Landry, M.G.; Meric-Bernstam, F.; Ferrari, M.Nanomedicine in cancer therapy: innovative trends and prospects. Cancer Sci., 2011, 102(7), 1247-1252.
208. Siddiqui, I.A.; Mukhtar, H. Nanochemoprevention by bioactive food components: a perspective. Pharm. Res., 2010, 27(6), 1054-1060.
209. Siddiqui, I.A.; Adhami, V.M.; Bharali, D.J.; Hafeez, B.B.; Asim, M.; Khwaja, S.I.; Ahmad, N.; Cui, H.; Mousa, S.A.; Mukhtar, H. Introducing nanochemoprevention as a novel approach for cancer control: proof of principle with green tea polyphenol epigallocatechin-3-gallate. Cancer Res., 2009, 69(5), 1712-1716.